Cerebral Infarct/Intracranial Cerebrovascular Disease by Grant, P. Ellen et al.
UNIT A1.1Cerebral Infarct/Intracranial
Cerebrovascular Disease
When imaging patients for intracranial cerebral vascular disease, the goals are (1) to as-
sess the degree of parenchymal injury and identify intraparenchymal hemorrhage; (2) to
determine if there are areas of altered perfusion that may be at risk for future injury; and
(3) to assess the intracranial arteries (patency as well as direction of flow). The corre-
sponding sequences are (1) T2 fast spin echo (FSE) and fluid attenuated inverson recov-
ery (FLAIR) to detect acute, subacute, and chronic injury, as well as diffusion-weighted
imaging to detect hyperacute injury and to determine age of injury, and gradient-echo
imaging to detect intracranial hemorrhages; (2) perfusion-weighted imaging; followed
by (3) 3-D time-of-flight MR angiography (TOF-MRA) to examine vascular patency,
and phase-contrast MRA (PC-MRA) to provide information regarding the direction of
flow in major vessels. The Basic Protocol can be used to evaluate stable patients with
acute, subacute, or chronic cerebrovascular symptoms. For a more tailored protocol in




STANDARD IMAGING FOR CEREBRAL INFARCT/INTRACRANIAL
CEREBROVASCULAR DISEASE
In order to perform the recommended perfusion and diffusion studies, a scanner with
echo planar capabilities is required (Table A1.1.1). MR angiography and the standard
anatomical MR imaging sequences included in the protocol do not require these faster
gradients. The parameters given here are optimized for a 1.5 Tesla (T) General Electric
(GE) LX system with version 8.35 software and may need modification for different
software versions, field strengths, or manufacturers.
Data processing is required for the following three sequences described in this protocol,
(1) 3-D TOF MRA, (2) diffusion-weighted imaging, and (3) perfusion-weighted imag-
ing. For optimal assessment of the volumetric 3-D TOF MRA data, separate volumes
of interest (VOI) of the left anterior, right anterior, and posterior circulation should be
created. Images from 15◦ rotations about the vertical axis should be saved. An additional
anterior circulation volume of interest should include both anterior cerebral arteries and
the region of the anterior communicating artery for visual inspection. Images from 15◦
rotations about the horizontal axis should also be saved. The authors recommend maxi-
mum intensity projection (MIP) over volume and surface reconstructions for assessment
of vascular patency, as algorithms in many software packages for surface and volume
reconstructions may smooth out and therefore obscure regions of arterial narrowing. All
of the authors’ MRA data is processed on a General Electric Medical Systems (GEMS)
Table A1.1.1 Equipment Requirements for Cerebral Vascular Assessment
Coil type Quadrature head coil
Gradient coil strength 25 mT/m (or whatever the system permits)
Slew rate ≥120 T/m/sec
Cardiac gating Not necessary
Peripheral gating Not necessary
Respirator If required by patient
Oxygen If required by patient
Motion cushions Useful
Use of contrast agents Yes
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Advantage Windows Workstation version 3.1P using standard GEMS Advantage Win-
dows software or FuncTool version 1.9M.
Diffusion imaging uses a spin echo (SE) echo planar sequence with additional bipolar
gradients around the 180◦ RF (radio frequency) pulse to increase the sensitivity to
molecular motion. This includes blood flow and water diffusion. Water diffusion is
highly anisotropic in the brain due to the highly ordered, tightly packed, and anisotropic
alignment of white matter tracts. When the bipolar gradient is oriented parallel to the
white matter tracts, water diffuses readily and signal loss occurs. If the gradients are
oriented perpendicular to the tracts in a direction of restricted water diffusion, no signal
loss occurs. Thus, the calculation of an apparent diffusion coefficient must balance these
anisotropic effects by measuring signal changes in ≥3 directions. In fact, a full description
would require the measurement of the full diffusion tensor but this is not usually used
clinically. The raw data from the diffusion-weighted sequence must be processed to
provide both the trace diffusion-weighted image (commonly referred to as the DWI)
and the apparent diffusion coefficient (ADC) map. Most diffusion sequences, including
the GE diffusion sequence, process the data automatically to provide the DWI and the
spin echo (SE) echo-planar (EP) T2 sequence but most do not automatically provide
the ADC map. The standard GE diffusion sequence can be processed on an Advantage
Windows Workstation version 3.1P using FuncTool version 1.9M to obtain ADC maps.
With the authors’ custom diffusion sequence, both DWI and ADC maps are automatically
obtained.
The perfusion of blood through the brain parenchyma can be monitored by tracking the
first passage of a rapid, well defined bolus of intravenously administered MR contrast
agent through the brain using echo planar imaging. There is a magnetic susceptibility
induced signal reduction as the bolus of paramagnetic contrast agent, confined to the
vascular compartment, passes through the brain. The time series data from the perfusion
sequence must be processed in order to obtain relative cerebral blood volume (rCBV),
time to peak (TTP), relative cerebral blood flow (rCBF), and mean transit time (MTT)
maps. The most accurate method for obtaining these parameters is to convert plots
of signal intensity versus time to plots of R2* = (1/T2*) versus time. A filter is
used to decrease high frequency noise prior to conversion of signal intensity to R2*.
Next, to determine the bolus dispersion in the smaller arterial feeders and tissue, the
bolus dispersion that occurs in the larger feeding artery is removed by deconvolving the
tissue curve with the arterial input curve, typically the middle cerebral artery. Although
the deconvolution step is not needed for the calculation of rCBV or TTP, the authors
typically calculate all parameters after the deconvolution. In order to reduce errors from
motion artifact, time points with excessive motion are deleted prior to processing. This
perfusion data analysis is custom software. However, perfusion analysis software is also
available with FuncTool version 1.9M that will give similar results.
For perfusion-weighted imaging in adults, the use of a double dose of contrast agent
injected by an MR compatible injection pump, such as a MEDRAD injector, at a rate
of 5 ml/sec through an 18-G angiocatheter is recommended. If an injection pump is not
available, perfusion sequences can still be performed with a hand injector using a 3-way
stopcock to inject a contrast bolus followed rapidly by a saline flush. The contrast agent
should be injected ∼10 sec after the start of the scan to provide enough images prior to
contrast agent arrival to determine the precontrast baseline and to provide enough images
after the contrast agent arrival to see the entire first pass of the bolus.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular




Current Protocols in Magnetic Resonance Imaging Supplement 14
Materials
Normal saline (0.9% NaCl), sterile
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, or Prohance)
Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no contraindications such
as cardiac pacemakers or other implants containing ferromagnetic materials. Also be
sure to find out if the patient has any health conditions that may require the presence
of special emergency equipment during the scanning procedure, or necessitate any
other precautions. Do not forget to ask if the patient has any drug allergies, and
document them.
Generally, standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who
can sit in the room during the scan and comfort the patient as needed. This companion
must be screened as well to ensure the absence of loose metal objects on the body or
clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should not talk, and should avoid or minimize swal-
lowing or other movement, during each scan—i.e., as long as the banging sounds
continue. Between scans, talking and swallowing are allowed in most cases, but
should be avoided when comparative positional studies are being performed; the
patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. If an 18-G i.v. is not already in place, an i.v. with an 18-G angiocatheter should be
started.
7. Have the patient mount onto the table. Either before or right after the patient lies
down, set up any triggering devices or other monitoring equipment that is to be
used.
8. Connect the MR compatible injection pump that is cleared of air and loaded with a
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injection to ensure that the i.v. is working properly so that contrast agent can be
injected when the perfusion sequence is performed.
9. Center the patient in a head or neck coil at the region where the key information
is desired. Make sure that the head and neck are constrained to prevent motion,
especially if high-resolution scans are to be run.
Generally the patient’s head is fixed so that the head is horizontal (not tilted) and the
neck and head lie along the axis of the patient table; other positions may be appropriate
depending on the needs at hand.
Most scanners have a special neck coil for MRA; otherwise, a head coil should be used
and the patient placed as far in as possible so that the bifurcation of the common carotid
artery into the internal and external carotid arteries can be imaged.
10. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
11. Use the centering light focused on the nasion to position the patient and put him or
her into the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table,
the table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
12. If the patient is unable to hold still, provide an appropriate sedative.
13. Program the 5 ml/sec injection rate for both contrast agent and saline, contrast agent
dose required (double dose by weight), saline flush required (typically 40 ml), and
10-sec time delay. Start the saline running to keep the vein open and arm the injection
pump. Do not inject the contrast agent until the perfusion sequence.
Sequence 1: Rapid sagittal T1 scout
14. To determine the patient’s position, a fast sagittal scout scan is performed using
the imaging sequence in Table A1.1.2. (Some medical centers may prefer a rapid
three-plane scout instead of this multislice sagittal scout.)
Sequence 2: Transverse diffusion
15. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse diffusion sequence. The transverse images should begin
at the foramen magnum and end at the top of the brain. Set up imaging parameters
as shown in Table A1.1.3.
16. Warn the patient that the sequence results in loud beeping (banging) noises and begin
the scan.
Data processing and viewing for sequence 2
17. Most diffusion sequences will perform a minimum of 4 sequences: three with orthog-
onal diffusion gradient directions and one with a minimal or no diffusion gradient.
Often, a fifth set of images is also provided, which combines the 3 orthogonal gradient
images to produce a set of images whose signal intensity is not affected by the diffusion
direction. This is the DWI. In order to obtain apparent diffusion coefficient (ADC) maps,
the images may need further processing. On a GE system, the ADC maps can be obtained
by processing on the Advantage Window Workstation version 3.1P using FuncTool version
1.9M.
Sequence 3: Transverse T2*-weighted gradient echo
18. To detect hemorrhages, this gradient echo sequence should be performed. From the
sagittal scout, select the image through the center of the brain to set up the locations
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Table A1.1.2 Rapid Sagittal T1 Scout
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal
Central slice or volume center Nasion
Echo time (TE) Minimum (at least 4.1 msec)
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 100 msec
Flip angle (FA) 60◦
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (x, y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (z) 7 mm
Number of slices 7
Slice gap 2 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Superior–inferior
Scan time 16 sec
Table A1.1.3 Transverse Diffusion
Patient position Supine
Scan type Single shot SE-EPI, diffusion
Imaging plane (orientation) Transverse
Pulse sequence database (PSD) epi2NV
Central slice or volume center Nasion
Echo time (TE) 101 msec
Repeat time (TR) 7500 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (x, y) 1.72 mm, 1.72 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (z) 5 mm
Number of slices 24
Slice gap 1 mm
Number of excitations (NEX) 3
Number of acquisitions (Nacq) 1
Read direction Right–left
Saturation pulses Fat saturation (automatic with EPI)
Control variables (CV) Ramp sampling = 1,
burst sampling = 0
b-value 1000 sec/mm2
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Table A1.1.4 Transverse T2-Weighted Gradient Echo
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 25 msec
Receiver bandwidth (RBW) 15.63 kHz
Repeat time (TR) 750 msec
Flip angle (FA) 20◦
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (x, y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (z) 5 mm
Number of slices 23
Slice gap 1 mm
Number of excitations (NEX) 2
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Flow compensation Yes
Scan time 3 min, 41 sec
Table A1.1.5 Transverse T2-Weighted FSE
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Nasion
Variable bandwidth Yes
Pulse sequence database (PSD) FSE-XL
Echo time (TE) 102 msec
Receiver bandwidth (RBW) 11.36 kHz
Echo train length (ETL) 12
Repeat time (TR) 6000 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (x, y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (z) 5 mm
Number of slices 28
Slice gap 1 mm
Number of excitations (NEX) 2
Number of acquisitions (Nacq) 1
Read direction Anterior–posterior
Flow compensation Yes
Extended dynamic range (EDR) Yes
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Table A1.1.6 Transverse FLAIR
Patient position Supine
Scan type Inversion recovery fast spin echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 140 msec
Receiver bandwidth (RBW) 20.83 kHz
Echo train length (ETL) 14
Repeat time (TR) 10,000 msec
Inversion time (TI) 2200 msec
Flip angle (FA) 180◦
Fields of view (FOVx, FOVy) 240 mm, 240 mm
Resolution (x, y) 0.94 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (z) 5 mm
Number of slices 14
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 2
Read direction Anterior–posterior
Scan time 5 min, 20 sec
the same as those chosen for the transverse diffusion sequence. Set up the imaging
parameters as shown in Table A1.1.4.
19. Warn the patient that the sequence is starting and begin the scan.
Sequence 4: Transverse T2-weighted FSE
20. From the sagittal scout, select the image through the center of the brain to set up
the locations for the transverse T2-weighted FSE sequence. The locations should be
the same as those chosen for the transverse diffusion sequence. Set up the imaging
parameters as shown in Table A1.1.5.
21. Warn the patient that the sequence is starting and begin the scan.
Sequence 5: Transverse FLAIR
22. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse FLAIR sequence. The locations should be the same as
those chosen for the transverse diffusion sequence. Set up the imaging parameters
as shown in Table A1.1.6.
23. Warn the patient that the sequence is starting and begin the scan.
Sequence 6: Transverse 3-D TOF MRA
24. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse 3-D TOF MRA sequence. Set up the imaging parameters
as shown in Table A1.1.7. Two slabs are posted on the midline sagittal image,
centered at the top of the sella turcica.
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Table A1.1.7 Transverse 3-D TOF MRA
Patient position Supine
Scan type 3-D short-TR gradient echo
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Central slice or volume center Nasion
Echo time (TE) 3.2 msec
Receiver bandwidth (RBW) 15.6 kHz
Repeat time (TR) 33 msec
Flip angle (FA) 20◦
Fields of view (FOVx, FOVy) 160 mm, 160 mm
Resolution (x, y) 0.63 mm, 0.84 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (z) 1.4 mm
Number of slices per slab 32
Number of slabs 2
Slab overlap 4 slices
Slice gap 0 mm
Number of excitations (NEX) 1





Extended dynamic range (EDR) Yes
Saturation pulses Superior
Magnetization transfer Yes
Vascular options Reprojections = 19◦
Collapse = on
Ramp pulse = inferior to superior
Scan time 6 min, 32 sec
Data processing and viewing for sequence 6
26. Once the transverse partitions from the 3-D TOF MRA are obtained, volumes of
interest (VOI) that select out the posterior circulation, the right anterior circulation,
and the left anterior circulation should be selected, and the maximum intensity
projections (MIPs) of these 3 VOIs rotated through 360◦ about the vertical axis,
saving images at 15◦ intervals. A fourth VOI that selects out both anterior circulations,
should be rotated through 360◦ about the horizontal axis, saving images at 15◦
intervals.
Sequence 7: Transverse 2-D phase contrast
27. From the sagittal scout, select the image through the center of the brain to set up the
locations for the transverse 2-D PC MRA sequence. Set up the imaging parameters
as shown in Table A1.1.8. Three slices are posted on the midline sagittal image,
centered at the top of the sella turcica.
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Table A1.1.8 Transverse 2-D Phase Contrast
Patient position Supine
Scan type 2-D Vascular phase contrast gradient
echo
Imaging plane (orientation) Transverse
Central slice or volume center Nasion
Echo time (TE) 6.7 msec
Repeat time (TR) 33 msec
Flip angle (FA) 20◦
Fields of view (FOVx, FOVy) 220 mm, 165 mm
Resolution (x, y) 0.86 mm, 1.03 mm
Number of data points collected (Nx, Ny) 256, 160
Display matrix (Dx, Dy) 256, 256
Slice thickness (z) 15 mm
Number of slices 3
Slice gap 0 mm
Number of excitations (NEX) 4




Vascular options Flow reconstruction type = phase
difference
Velocity encoding = 80 cm/sec
Acquired flow directions = all
Collapse = on
Flow analysis = off
Additional flow images = R/L, A/P,
S/I, MAG
Scan time 2 min, 6 sec
Sequence 8: Transverse perfusion
29. Using the transverse FSE T2-weighted images, find the slice location where the
middle cerebral arteries are best seen. Using the imaging parameters as shown in
Table A1.1.9, set up the transverse images starting at the same location that the MCA’s
(middle cerebral artery) were identified on the FSE T2-weighted images. Typically,
only 10 or 11 slices can be obtained in the given TR interval. The slice thickness and
gap can be modified so that the perfusion study covers any diffusion abnormality.
30. Check that the injection pump is ready to inject the contrast agent and that the
injection of the contrast agent is set to start 10 sec after the scan begins.
31. Warn the patient that the sequence is starting and that part of the way through the
scan the i.v. injection will occur. Warn the patient that a cool sensation may be felt
during the injection. Begin the scan.
Two doses of contrast agent (0.2 mmol/kg) are given here.
Process data and view for sequence 8
32. Process the perfusion images.
The perfusion images can be processed on an Advantage Windows Workstation version
3.1P using FuncTool version 1.9M to give maps of relative cerebral blood volume (rCBV),
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Table A1.1.9 Transverse Perfusion
Patient position Supine
Scan type Single shot SE-EPI
Imaging plane (orientation) Transverse
Variable bandwidth Yes
Pulse sequence database (PSD) epi2perf
Central slice or volume center Nasion
Echo time (TE) 65 msec
Repeat time (TR) 1520 msec
Flip angle (FA) 90◦
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (x, y) 1.72 mm, 1.72 mm
Number of data points collected (Nx, Ny) 128, 128
Display matrix (Dx, Dy) 128, 128
Slice thickness (z) 5 or 6 mm
Number of slices 11
Slice gap 1 mm
Number of excitations (NEX) 1
Number of acquisitions (Nacq) 1
Read direction Left–right
Slice location Inferior slice to include MCA
Multi-phase 46 phases per location, minimum
delay between acquisitions
Slice series Interleaved
Control variables (CV) Ramp sampling = on,
burst sampling = off
Scan time 1 min, 11 sec
ALTERNATE
PROTOCOL
RAPID IMAGING FOR ACUTE CEREBRAL INFARCT
When an acute arterial stroke is suspected, MR imaging with diffusion and perfusion
imaging provides information that is necessary for rapid, optimal patient treatment. If
the patient is unstable, if the patient is an intra-arterial thrombolysis candidate, or if the
patient must be squeezed into an already over-booked MR schedule, imaging is kept
to a minimum. The choice of T2-weighted sequence for sequence 3 depends on user
preference. Arguments for T2-weighted FSE sequence include shorter scan time with
good spatial resolution, for FLAIR, increased sensitivity to cortical and periventricular
hyperintensity, and for gradient echo, increased sensitivity to blood products.
Set up patient and equipment
1. Use the same equipment and perform the same equipment and patient set up as in
Basic Protocol, steps 1 to 13.
Sequence 9: Rapid sagittal scout
2. Run rapid sagittal scout (see Basic Protocol, sequence 1, step 14).
Sequence 10: Transverse diffusion
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Sequence 11: Transverse T2-weighted FSE
4. Run transverse T2-weighted FSE sequence (see Basic Protocol, sequence 4, steps 20
and 21).
Sequence 12: Transverse perfusion
5. Run transverse perfusion sequence (see Basic Protocol, sequence 8, steps 29 and 32).
Sequence 13: 2-D phase contrast MRA
6. Run transverse 2-D phase contrast MRA sequence (see Basic Protocol, sequence 7,
steps 27 and 28).
COMMENTARY
Background Information
Strokes are the third leading cause of death
and the major cause of adult long-term dis-
ability. The concept of “Brain Attack” has
emphasized the importance of rapid treatment
in stroke management. To enable rapid treat-
ment, rapid detection of an acute stroke is es-
sential. With the high sensitivity of diffusion-
weighted imaging to acute stroke (Gonzalez
et al., 1999), it has become the mainstay of
stroke evaluation. In animal models, diffusion-
weighted imaging can detect acute ischemic
injury as early as 10 min after arterial occlu-
sion (Kucharczyk et al., 1991). In the authors’
clinical experience, diffusion-weighted imag-
ing can detect hyperacute infarcts in humans
as early as 30 min after a witnessed event, well
before the standard T2-weighted or FLAIR
imaging becomes abnormal. In the subacute
stages, when there is mixture of chronic and
recent events, diffusion-weighted imaging is
helpful in determining which of many bright
areas on T2-weighted images is the more re-
cent lesion. The DWI, when combined with
the ADC map, can also help determine the age
of the lesion (Warach et al., 1995; Burdette
et al., 1998; 1999).
Perfusion-weighted imaging provides com-
plementary information about blood volume in
and blood flow through the tissue. This infor-
mation may be helpful in assessing the risk
for infarct growth and the degree of hemo-
dynamic compromise (Sorensen et al., 1996;
Rordorf et al., 1998; Sorensen et al., 1999).
In most clinical settings where imaging is per-
formed at least a few hours after the event, the
area of decreased rCBV best predicts the fi-
nal infarct size (Sorensen et al., 1999). When
the areas of decreased relative cerebral blood
flow and elevated mean transit time are signif-
icantly larger than the diffusion abnormality,
the ipsilateral ICA (internal carotid artery) or
MCA is typically occluded. When such areas
of “mismatch” between relative blood flow and
diffusion exist, there is an increased risk that
the infarct will increase in size, although the
mechanism of this interval growth is not yet
clear.
The 3-D TOF MRA is useful for determin-
ing the patency of major vessels and the degree
of intracranial atherosclerotic disease. The
2-D PC MRA gives a lower resolution evalua-
tion of vessel patency but is significantly faster
and therefore more appropriate when time is
an issue. It is adequate to detect vessel cut-off.
The 2-D PC MRA also provides information
regarding the direction of flow in major ves-
sels that can help determine routes of collateral
flow in cases with vascular occlusion.
The standard anatomical MR sequences,
namely the FLAIR and T2-weighted FSE se-
quences, allow us to assess the condition of
the brain parenchyma and determine if there
is evidence of old ischemic events. The T2*-
weighted gradient echo sequence is probably
as accurate as computed tomography (CT) at
determining if there is evidence of blood prod-




For diffusion-weighted imaging, the “b-
value” is a critical parameter in determin-
ing ADC values for different tissues, partic-
ularly when the b-value is between 1000 and
2000 sec/mm2 (Le Bihan et al., 1991; Mulkern
et al., 1999. The human studies on stroke imag-
ing in the literature have all been done with
b-values close to 1000 sec/mm2 and the
protocol described here uses a b-value of
1000 sec/mm2. At this b-value, there is a good
signal to noise ratio (SNR) and the ADC values
of gray and white matter are essentially equal.
With increasing b-values, the SNR drops and
ADC values of gray and white matter start
to diverge. Many systems now have the ca-
pability of doing diffusion-weighted imaging
at b-values >1000 sec/mm2 but extreme cau-
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results. The TE is also an important parame-
ter in diffusion-weighted imaging. To optimize
SNR, the shortest possible TE is used. TR has
no effect on image contrast. With increasing or
decreasing TR, the number of slices obtained
increases or decreases.
For perfusion-weighted imaging, a spin
echo echo-planar sequence or a gradient echo
echo-planar sequence can be used. In this pro-
tocol, a spin echo echo-planar sequence is cho-
sen because it has a greater contribution from
small vessels (Boxerman et al., 1995). The
trade-off is a decreased change in signal with
the bolus of contrast compared to the gradient
echo sequence. In order to improve the signal
change, a double dose of contrast agent is used
for the spin echo sequence that results in a sig-
nal drop of at least 10%. In perfusion weighted
imaging, increasing TR increases the number
of slices available but at the cost of increas-
ing the temporal spacing between points on
the signal intensity versus time curve. Short
spacing in time enables better characteriza-
tion of the bolus. The TR chosen in this se-
quence is what the authors determined to be
the best compromise between these two fac-
tors. The TE is also an important parameter to
optimize. Varying the TE not only alters the
SNR but also changes the contribution of dif-
ferent vessel sizes on relative blood volume
and relative blood flow calculations (Boxer-
man et al., 1995). The authors have chosen a
TE of 65 msec to best optimize SNR and the
contribution of small diameter vessels.
Important basic parameters in MR angiog-
raphy include TR, flip angle, and TE. The TR
is chosen to be long enough to avoid satu-
ration of flowing blood but short enough to
improve contrast by saturation of background
tissue. TE is typically minimized to minimize
flow related dephasing. The flip angle must be
optimized to be short enough to avoid satura-
tion of small vessels but long enough to give
sufficient suppression of background tissue.
Most vendors have ramped flip angles where
the flip angle is gradually increased in the di-
rection of the flowing blood to minimize satu-
ration. Interpolation, performed by zero filling
the acquisition matrix (number of data points
collected) in k-space, is helpful in reducing
partial volume averaging effects. Typically, the
authors interpolate in both the slice select and
the phase encoding directions. In cases with
high-grade stenosis, turbulence may result in
an over estimation of the degree of vascular
narrowing. Decreasing the TR and flip angle
can minimize these effects at the cost of de-
creased background suppression. Other alter-
natives include contrast agent administration
or black blood techniques (see Table A7.4.10).
Anticipated Results
Diffusion-weighted imaging should allow
detection of ischemic necrosis as early as
30 min and at least as long as 10 days after
the ischemic event. Perfusion-weighted imag-
ing provides complementary information on
the relative blood volume and blood flow that
helps determine areas of hemodynamic com-
promise. The MRA allows assessment of the
degree of underlying cerebral vascular disease
and can detect areas of vascular occlusion.
Time Considerations
The full assessment of patients at risk for
an ischemic event often includes neck MR an-
giography as well as the Basic Protocol de-
scribed above. This results in a study of at
least 45 min in length. When time is crucial
for optimal patient treatment, as in candidates
for intra-arterial thrombolysis, the Alternate
Protocol is used to minimize imaging time yet
provides the critical information required for
decisions on urgent patient management.
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